FIELD: biotechnology.
SUBSTANCE: calibration panel of control positive samples with the concentrations of foot and mouth disease virus RNA is prepared. Foot and mouth disease virus RNA is isolated from the vaccine raw material. The eluates are added to the mixture of components for RT-PCR-PB. RT-PCR-PB is conducted, followed by detection of amplification products using a fluorescent PCR detector. The magnetude of the amplification threshold cycle is determined. The relationship between the threshold amplification cycle and the concentration of the 146S component of the foot and mouth disease virus in the raw material is determined.
EFFECT: invention allows rapid and highly-reliable determination of foot-and-mouth disease 146S component concentration in vaccine raw materials based on RT-PCR-PB, followed by application of the developed negative regression model.
4 cl, 1 dwg, 7 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SPECTROMETRIC DETERMINATION OF CONCENTRATION OF 146S FOOT-AND-MOUTH DISEASE VIRUS PARTICLES IN NON-INACTIVATED RAW MATERIAL FOR A VACCINE BY ESTIMATING THE NUMBER OF MOLECULES OF VIRAL RNA RELEASED AFTER IMMUNE CAPTURE OF VIRIONS | 2019 |
|
RU2712769C1 |
O/KENYA/2017 STRAIN OF FMD VIRUS APHTAE EPIZOOTICAE GENOTYPE O/EA-2 FOR THE MANUFACTURE OF BIOLOGICAL PRODUCTS FOR THE DIAGNOSIS AND SPECIFIC PREVENTION OF FMD GENOTYPE O/EA-2 | 2022 |
|
RU2793828C1 |
O N 2241/Ethiopia/2011 STRAIN OF FMD VIRUS APHTAE EPIZOOTICAE GENOTYPE O/EA-3 FOR MANUFACTURE OF BIOPREPARATIONS FOR DIAGNOSIS AND SPECIFIC PREVENTION OF FMD | 2023 |
|
RU2809223C1 |
FMD CULTURE INACTIVATED SORBED VACCINE FROM A/AFGHANISTAN/2017 STRAIN OF A/ASIA/IRAN-05FAR-11 NEW GENOTYPE | 2022 |
|
RU2798293C1 |
O N 2620/ORENBURG/2021 STRAIN OF FOOT AND MOUTH DISEASE VIRUS APHTAE EPIZOOTICAE GENOTYPE O/ME-SA/IND-2001E FOR PRODUCTION OF BIOLOGICAL PRODUCTS FOR DIAGNOSIS AND SPECIFIC PREVENTION OF FOOT AND MOUTH DISEASE | 2023 |
|
RU2806606C1 |
FMD CULTURE INACTIVATED SORBED VACCINE FROM A/Iran/2018 STRAIN OF A/ASIA/Iran-05 NEW GENOTYPE | 2022 |
|
RU2799605C1 |
VACCINE FOR EARLY PROTECTION AGAINST FOOT-AND-MOUTH DISEASE FROM STRAIN A 2205/G IV CULTURAL INACTIVATED EMULSION | 2021 |
|
RU2772713C1 |
METHOD FOR DETERMINING THE INFECTIVITY TITER OF THE FMD VIRUS IN NON-INACTIVATED RAW MATERIALS FOR VACCINES USING THE METHOD OF REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION IN REAL TIME | 2017 |
|
RU2674076C1 |
A/TANZANIA/2013 STRAIN OF APHTAE EPIZOOTICAE FOOT AND MOUTH DISEASE VIRUS OF A/AFRICA/G-I GENOTYPE FOR MANUFACTURE OF BIOLOGICAL PRODUCTS FOR DIAGNOSTICS AND SPECIFIC PREVENTION OF FOOT AND MOUTH DISEASE VIRUS OF A/AFRICA/G-I GENOTYPE | 2023 |
|
RU2810133C1 |
A N2269/VNIIZZH/2015 STRAIN OF TYPE A APHTAE EPIZOOTICAE FOOT-AND-MOUTH DISEASE VIRUS FOR CONTROL OF ANTIGENIC AND IMMUNOGENIC ACTIVITY AND FOR MANUFACTURE OF BIOPREPARATIONS FOR DIAGNOSIS AND SPECIFIC PREVENTION OF TYPE A FOOT-AND-MOUTH DISEASE | 2016 |
|
RU2640261C1 |
Authors
Dates
2017-05-18—Published
2016-10-14—Filed